Last updated: July 17, 2026

Application No. 18/707,062

SELECTION AND TREATMENT OF SUBJECTS HAVING A CIRCULATING MYELOID CELL INFLAMMATORY PHENOTYPE

Non-Final OA

Filed

May 02, 2024

Priority

Nov 02, 2021 — provisional 63/274,931 +1 more

Examiner

ROBINSON, MIKHAIL O'DONNEL

Art Unit

Tech Center

Assignee

The Board of Trustees of the Leland Stanford Junior University

OA Round

1 (Non-Final)

This examiner grants 58% of cases after interview

— +42.7% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 120 resolved cases, 2023–2026

Examiner Intelligence

ROBINSON, MIKHAIL O'DONNEL View full profile →

Grants 58% of resolved cases

Career Allowance Rate

69 granted / 120 resolved

-2.5% vs TC avg

Strong +43% interview lift

Without

With

+42.7%

Interview Lift

resolved cases with interview

Typical timeline

3y 4m

Avg Prosecution

43 currently pending

Career history

159

Total Applications

across all art units

Statute-Specific Performance

§101

0.9%

-39.1% vs TC avg

§103

64.5%

+24.5% vs TC avg

§102

11.7%

-28.3% vs TC avg

§112

6.8%

-33.2% vs TC avg

Black line = Tech Center average estimate • Based on career data from 120 resolved cases

Prosecution Timeline

May 02, 2024

Application Filed

Apr 23, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/264,298

Patent 12673954

BENZOFURAN COMPOUNDS AS STING AGONISTS

2y 11m to grant Granted Jul 07, 2026

17/254,256

Patent 12667551

RENAL FUNCTION MAINTENANCE AND PROTECTION AGENT, AND METHOD FOR EVALUATING EFFECT THEREOF

5y 6m to grant Granted Jun 30, 2026

17/792,193

Patent 12668581

PROCESSES FOR THE PREPARATION OF GLASDEGIB AND SALT THEREOF AND SOLID STATE FORMS OF GLASDEGIB MALEATE AND PROCESS FOR PREPARATION THEREOF

3y 11m to grant Granted Jun 30, 2026

17/716,965

Patent 12655154

CRYSTALLINE SOLVATED FORMS OF N-(4-(1-(2,6-DIFLUOROBENZYL)-5- ((DIMETHYLAMINO)METHYL)-3-(6-METHOXY-3-PYRIDAZINYL)-2,4-DIOXO-1,2,3,4- TETRAHYDROTHIENO[2,3-D]PYRIMIDIN-6-YL)PHENYL)-N'-METHOXYUREA

4y 2m to grant Granted Jun 16, 2026

17/400,468

Patent 12649725

Synthesis of small molecules inspired by Phomoxanthone A

4y 10m to grant Granted Jun 09, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

58%

Grant Probability

99%

With Interview (+42.7%)

3y 4m (~1y 1m remaining)

Median Time to Grant

Low

PTA Risk

Based on 120 resolved cases by this examiner. Grant probability derived from career allowance rate.